Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss

Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss in Overweight and Obese Women, a Randomized Clinical Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03171961

Enrollment

120

Registered

2017-05-31

Start date

2017-06-20

Completion date

2020-03-11

Last updated

2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

weight loss, Diet, online visit, clinic visit

Brief summary

Online visit and online counseling via telemedicine technology is a new service for obese people who wish to lose weight but because of their active lifestyle and time limitation cannot come to clinic. The purpose of this study was to examine the efficacy this technology-based intervention on weight loss in obese and overweight female adults.

Interventions

BEHAVIORALonline visit group

subjects has online visit with dietitian every 2 weeks+diet

BEHAVIORALClinic visit group

Clinic visit group ,subjects has every 2 weeks in person visit at clinic+diet

BEHAVIORALself-directed group

self-directed group receives nutritional information via web and their energy needs for weight loss

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Must be female * Must be 18-45 years of age. * Must have Body mass index (BMI) between 27-35 kg/ m². * Must be able to have moderate exercise. * Must be interested to have weight loss. * Have access to the internet via broad- band ADSL or Mobile 4G

Exclusion criteria

* Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months. * Taking medications that could affect metabolism or change body weight. * Report heart problems, chest pain, and cancer within the last five years. * Smoking * Menopause * Diagnosis of any chronic disease such as fatty liver, cancer, chemo/radio therapy, heart disease, immune compromised conditions, abnormal thyroid hormone level.

Design outcomes

Primary

Measure	Time frame	Description
weight	24 Weeks	kg

Secondary

Measure	Time frame	Description
Fasting blood glucose	24 Weeks	mmol/l
Fasting insulin level	24 Weeks	mU/l
HbA1c	24 Weeks	score
Waist circumference	24 Weeks	cm
lipid profiles	24 Weeks	mmol/l
liver function tests	24 Weeks	U/l
HOMA-IR	24 Weeks	Percentage (%)

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026